SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-441091
Filing Date
2013-11-14
Accepted
2013-11-14 06:51:50
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d601781d10q.htm 10-Q 358703
2 EX-31.1 d601781dex311.htm EX-31.1 5692
3 EX-32.1 d601781dex321.htm EX-32.1 3122
  Complete submission text file 0001193125-13-441091.txt   3242706

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxii-20130930.xml EX-101.INS 381674
5 XBRL TAXONOMY EXTENSION SCHEMA rxii-20130930.xsd EX-101.SCH 26387
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20130930_cal.xml EX-101.CAL 42407
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20130930_def.xml EX-101.DEF 172049
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20130930_lab.xml EX-101.LAB 285259
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20130930_pre.xml EX-101.PRE 225115
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54910 | Film No.: 131216721
SIC: 2834 Pharmaceutical Preparations